- Home
- SCLXW vs AIRTP Comparison
SCLXW vs AIRTP Comparison
Compare SCLXW & AIRTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- AIRTP
- Stock Information
- Founded
- SCLXW N/A
- AIRTP N/A
- Country
- SCLXW United States
- AIRTP United States
- Employees
- SCLXW 111
- AIRTP 646
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- AIRTP Air Freight/Delivery Services
- Sector
- SCLXW Health Care
- AIRTP Consumer Discretionary
- Exchange
- SCLXW Nasdaq
- AIRTP Nasdaq
- Market Cap
- SCLXW N/A
- AIRTP N/A
- IPO Year
- SCLXW N/A
- AIRTP N/A
- Fundamental
- Price
- SCLXW $0.46
- AIRTP $19.25
- Analyst Decision
- SCLXW
- AIRTP
- Analyst Count
- SCLXW 0
- AIRTP 0
- Target Price
- SCLXW N/A
- AIRTP N/A
- AVG Volume (30 Days)
- SCLXW 4.0K
- AIRTP N/A
- Earning Date
- SCLXW 03-07-2025
- AIRTP N/A
- Dividend Yield
- SCLXW N/A
- AIRTP N/A
- EPS Growth
- SCLXW N/A
- AIRTP N/A
- EPS
- SCLXW N/A
- AIRTP N/A
- Revenue
- SCLXW $55,152,000.00
- AIRTP N/A
- Revenue This Year
- SCLXW N/A
- AIRTP N/A
- Revenue Next Year
- SCLXW N/A
- AIRTP N/A
- P/E Ratio
- SCLXW N/A
- AIRTP N/A
- Revenue Growth
- SCLXW 22.02
- AIRTP N/A
- 52 Week Low
- SCLXW $0.18
- AIRTP N/A
- 52 Week High
- SCLXW $0.18
- AIRTP N/A
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- AIRTP 63.03
- Support Level
- SCLXW N/A
- AIRTP $17.56
- Resistance Level
- SCLXW N/A
- AIRTP $19.55
- Average True Range (ATR)
- SCLXW 0.00
- AIRTP 0.27
- MACD
- SCLXW 0.00
- AIRTP 0.02
- Stochastic Oscillator
- SCLXW 0.00
- AIRTP 84.92
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About AIRTP Air T Inc. Air T Funding Alpha Income Trust Preferred Securities
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.